ProfileGDS5678 / 1451981_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 66% 67% 66% 69% 67% 66% 65% 66% 66% 67% 67% 67% 69% 67% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 14.0235366
GSM967853U87-EV human glioblastoma xenograft - Control 24.0353967
GSM967854U87-EV human glioblastoma xenograft - Control 34.0175866
GSM967855U87-EV human glioblastoma xenograft - Control 44.3552869
GSM967856U87-EV human glioblastoma xenograft - Control 54.0085667
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 14.0256466
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.9448465
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 34.0166566
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 44.0162366
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 14.0372567
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 24.0227367
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 34.0233267
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 44.2322869
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 54.024767